Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3928/23258160-20240819-01 | DOI Listing |
Ophthalmic Surg Lasers Imaging Retina
December 2024
JCO Mesenchymal-epithelial transition (MET) signaling pathway plays a role in the pathogenesis of selected patients with papillary renal cell carcinoma (PRCC). In the phase II PAPMET trial (ClinicalTrials.gov identifier: NCT02761057), cabozantinib significantly prolonged progression-free survival and improved objective response rate compared with sunitinib in patients with advanced PRCC.
View Article and Find Full Text PDFJ Clin Oncol
October 2024
Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Complutense University and Ciberonc, Madrid, Spain.
Ophthalmic Surg Lasers Imaging Retina
August 2024
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!